XML 46 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Shares
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Shares Shares
a) Common shares
Common sharesTreasury sharesCommon shares, net of treasury shares
Issued and outstanding at December 31, 202031,011,831 (1,845,201)29,166,630 
Issued upon exercise of stock options125,000 — 125,000 
Retired through share purchase program(1,113,903)— (1,113,903)
Purchase of treasury shares— (21,503)(21,503)
Settlement of certain equity classified stock-based compensation— 301,891 301,891 
Issued and outstanding at December 31, 202130,022,928 (1,564,813)28,458,115 
Retired through share purchase program(2,195,646)— (2,195,646)
Purchase of treasury shares— (26,012)(26,012)
Settlement of certain equity classified stock-based compensation— 184,364 184,364 
Issued and outstanding at December 31, 202227,827,282 (1,406,461)26,420,821 
Upon settlement of certain equity classified stock-based compensation during the year ended December 31, 2022, the Company withheld the cash equivalent of 112,583 shares for $1,591 to satisfy the recipient tax withholding requirements (year ended December 31, 2021 - 274,359 shares for $5,134).
b) Net income per share
Year ended December 31, 20222021
Net income$67,372 $51,408 
Interest from convertible debentures (after tax)5,893 4,410 
Diluted net income available to common shareholders$73,265 $55,818 
Weighted-average number of common shares27,406,140 28,325,489 
Weighted-average effect of dilutive securities
Dilutive effect of treasury shares1,485,275 1,707,718 
Dilutive effect of stock options— 47,767 
Dilutive effect of 5.00% convertible debentures
2,095,236 2,095,236 
Dilutive effect of 5.50% convertible debentures
3,020,199 1,770,747 
Weighted-average number of diluted common shares34,006,850 33,946,957 
Basic net income per share$2.46 $1.81 
Diluted net income per share$2.15 $1.64 
For the year ended December 31, 2022, all securities were dilutive (year ended December 31, 2021, all securities were dilutive).
On April 11, 2022, the Company commenced a normal course issuer bid ("NCIB") under which a maximum number of 2,113,054 common shares were authorized to be purchased. During the year ended December 31, 2022, the Company purchased and subsequently cancelled 2,113,054 shares under this NCIB, which resulted in a decrease to common shares of $16,824 and a decrease to additional paid-in capital of $15,827. This NCIB is now complete, with the purchase and cancellation of the maximum number of shares.
During the year ended December 31, 2022, the Company completed a NCIB which commenced on April 9, 2021, upon the purchase and cancellation of 82,592 common shares, which resulted in a decrease to common shares of $665 and a decrease to additional paid-in capital of $816.
c) Dividends
Date declaredPer shareShareholders on record as ofPaid or payable to shareholdersTotal paid or payable
Q1 2021February 16, 2021$0.04 March 4, 2021April 9, 2021$1,123 
Q2 2021April 27, 2021$0.04 May 28, 2021July 9, 2021$1,123 
Q3 2021July 27, 2021$0.04 August 31, 2021October 8, 2021$1,137 
Q4 2021October 26, 2021$0.04 November 30, 2021January 7, 2022$1,137 
Q1 2022February 15, 2022$0.08 March 4, 2022April 8, 2022$2,277 
Q2 2022April 26, 2022$0.08 May 27, 2022July 8, 2022$2,232 
Q3 2022July 26, 2022$0.08 August 31, 2022October 7, 2022$2,127 
Q4 2022October 25, 2022$0.08 November 30, 2022January 6, 2023$2,098